Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesLong-term effects of weight-reducing drugs in hypertensive patients
Cochrane Reviews, 07/14/09
Siebenhofer A et al. - Drugs such as orlistat, sibutramine or rimonabant are sometimes suggested to assist in weight reduction and blood pressure reduction. Orlistat and sibutramine have been shown to modestly reduce weight. Orlistat also reduced blood pressure but sibutramine increased blood pressure. No study investigating rimonabant was found. No evidence is available for effects of any of these drugs on death or morbidity. The most frequent side effects were gastrointestinal for orlistat and dry mouth, constipation and headache for sibutramine.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 70%
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension. Inter-American Society of Hypertension
Hypertension, 10/29/09
Relevance Score: 69%
Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension
Journal of Human Hypertension, 11/04/09
Relevance Score: 68%
Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant
Nutrition, Metabolism & Cardiovascular Diseases, 10/20/09
Relevance Score: 68%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 68%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European–American population
Atherosclerosis, 12/07/09
Qualitative assessment of previous evidence and an updated meta-analysis confirms lack of association between the ESR1 rs2234693 (PvuII) variant and coronary heart disease in men and women
Atherosclerosis, 12/07/09
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Today in Family Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Both weight-bearing and non-weight-bearing exercise improved function in patients with knee osteoarthritis
Evidence-Based Medicine, 12/07/09
Once-only flexible sigmoidoscopy screening for colorectal cancer may not reduce colorectal cancer incidence or mortality
Evidence-Based Medicine, 12/07/09
Today in Internal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Patient Safety Education at U.S. and Canadian Medical Schools: Results From the 2006 Clerkship Directors in Internal Medicine Survey
Academic Medicine, 12/07/09
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor